NCT00381979

Brief Summary

The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Jan 2004

Longer than P75 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 26, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 28, 2006

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2007

Completed
Last Updated

October 22, 2015

Status Verified

September 1, 2015

Enrollment Period

3.8 years

First QC Date

September 26, 2006

Last Update Submit

October 21, 2015

Conditions

DepressionAnxiety

Keywords

DepressionAnxietyAdolescentsTreatmentSupportive Expressive Therapy

Outcome Measures

Primary Outcomes (3)

  • BDI

    pre and post

  • MASC

    pre and post

  • Measures collected at pre, post, and follow-up

    pre and post

Secondary Outcomes (6)

  • YSR

    pre and post

  • CBCL

    pre and post

  • FAM

    pre and post

  • CRI

    pre and post

  • SSRS

    pre and post

  • +1 more secondary outcomes

Study Arms (1)

1

EXPERIMENTAL

set

Other: Supportive Expressive Therapy

Interventions

Supportive Expressive TherapyOTHER
Also known as: therapy
1

Eligibility Criteria

Age15 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • year old, male \& female adolescents, primary diagnosis of depression or anxiety disorder.
  • Clients with co-morbid diagnoses, suicidal ideation or taking medication would not necessarily be excluded if deemed able to partake in the proposed therapy.
  • Medication dose needs to be stable for 4-6 weeks prior to starting therapy.

You may not qualify if:

  • Clients who are actively psychotic, developmentally delayed, or have a diagnosis of bipolar disorder.
  • Clients who are not fluent in English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Addiction and Mental Health

Toronto, Ontario, M5T1R8, Canada

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
psychologist

Study Record Dates

First Submitted

September 26, 2006

First Posted

September 28, 2006

Study Start

January 1, 2004

Primary Completion

October 1, 2007

Study Completion

October 1, 2007

Last Updated

October 22, 2015

Record last verified: 2015-09

Locations

CA(1)